C-Peptide to Glucose Ratio

ورودی‌های بالینی بیمار

حداقل ۰.۰۱ — حداکثر ۵۰ • واحد: ng/mL

حداقل ۱۰ — حداکثر ۱۰۰۰ • واحد: mg/dL

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
c peptide glucose ratio
—ratio
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Insulin Secretion Deficit0–2
  • Impaired Insulin Secretion2–5
  • Preserved Insulin Secretion5–999
Direct Clinical Answer

The C-Peptide to Glucose Ratio calculates assessing beta cell secretory function in patients with diabetes/pre-diabetes. Key inputs include c peptide. Scores guide titrating insulin infusion protocols, managing fluid-electrolyte resuscitation, and long-term risk reduction. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Assesses beta cell secretory function in patients with diabetes/pre-diabetes. The C-peptide to glucose ratio (CGR) is a simple marker that helps evaluate endogenous insulin secretion capacity and can guide diabetes management decisions.

Clinical Indication

The C-Peptide to Glucose Ratio is indicated for bedside clinical practice to support Assesses beta cell secretory function in patients with diabetes/pre-diabetes. The C-peptide to glucose ratio (CGR) is a simple marker that helps evaluate endogenous insulin secretion capacity and can guide diabetes management decisions.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with diabetes mellitus, diabetic ketoacidosis (DKA), hyperosmolar hyperglycemic state, thyroid storm, or adrenal crisis. Clinical application is indicated across Endocrinology clinics, inpatient metabolic services, and acute diabetes care units.

Limitations & Contraindications

Severe hyperglycemia lowers measured serum sodium; corrected sodium equations must guide intravenous fluid selection.

Clinical Pearls & Action Plan

Serial monitoring of serum electrolytes, potassium kinetics, venous pH, and anion gap is mandatory during acute metabolic crisis management. Guideline pearl: Not recommended for patients with chronic kidney disease as C-peptide clearance is reduced.

Formula & Variables:

C-peptide to glucose ratio = serum C-peptide level (ng/mL) / plasma glucose level (mg/dL) × 100

Input Parameters

NameTypeRequiredDescription
c_peptidefloatYesSerum C-peptide level(ng/mL)
glucosefloatYesPlasma glucose level(mg/dL)

Score Interpretation & Guidance

RangeStageDescription
0–2Insulin Secretion DeficitSevere beta cell dysfunction
2–5Impaired Insulin SecretionModerate beta cell dysfunction
5–999Preserved Insulin SecretionAdequate beta cell function

Evidence-Based References (EBM)

  • Saisho Y. Postprandial C-Peptide to Glucose Ratio as a Marker of β Cell Function: Implication for the Management of Type 2 Diabetes. Int J Mol Sci. 2016 May 6;17(5):744. doi: 10.3390/ijms17050744.DOI: 10.3390/ijms17050744
  • Fritsche A, Heni M, Peter A, Stefan N, Häring HU, Wagner R. Different Effects of Lifestyle Intervention in High- and Low-Insulin Secretors. Diabetes Care. 2023 Feb 1;46(2):290-297. doi: 10.2337/dc22-1523.DOI: 10.2337/dc22-1523
  • Iwao T, Sakata N, Takeuchi T, Nishimura K, Ohtake S, Akaiwa Y, Kawamura I, Ito A, Yoshida A. Postprandial Serum C-Peptide to Plasma Glucose Ratio Predicts Future Insulin Therapy in Patients with Type 2 Diabetes: A 10-Year Prospective Cohort Study. J Diabetes Investig. 2021 Jan;12(1):68-75. doi: 10.1111/jdi.13304.DOI: 10.1111/jdi.13304

Related calculators